American Express shares move lower on fourth quarter profit miss

American Express reported Q4 (ended Dec. 31, 2025) EPS of $3.53 versus a consensus cited at $3.50 and revenues net of interest of $18.98 billion, up 10% year-over-year, while expenses rose 10% to $14.5 billion reflecting operating investments including new Platinum card perks. Full-year 2025 net income was $10.8 billion (up 7%), FY EPS $15.38 and total revenues $72.2 billion (+10%); billed business in Q4 was $445.1 billion (+9%) with cardmember spending +9% (8% FX-adjusted). Management guided 2026 revenue growth of 9–10% and EPS of $17.30–$17.90; shares traded down roughly 3% on the print.

Analysis

Market structure: AMEX (AXP) is trading like a growth-at-a-premium consumer finance play — winners include premium travel/dining partners (Resy, high-end restaurants) and card-processing peers that pick up volume; losers are lower-end card issuers and discount-focused merchants if affluent spend re-accelerates. The 9% YoY billed business and 8% FX‑adjusted spend signal robust demand among affluent cohorts, supporting AMEX’s pricing power on annual fees but pressuring near-term margins from $400 Platinum dining credits and tech investments. Cross-asset: expect modest AXP equity volatility, slight CDS tightening if guidance holds, limited FX/commodity impact, and potential positive spillover to payment networks (V, MA) versus cyclically sensitive banks (BAC, C).

Risk assessment: Tail risks include regulatory pressure on merchant fees or interchange (probability medium, impact high), an abrupt consumer-income shock raising losses (linked to unemployment >6%), or a costly rollout/GenAI mishap. Immediate (days) risk: >3% share moves around prints; short-term (weeks–months): execution of perks and cost control; long-term (years): LTV lift if retention improves. Hidden dependencies: Platinum uptake depends on merchant capacity and card activation rates, and net interest income remains sensitive to yield curve moves and loan loss trends. Key catalysts: Feb–May consumer spend data, next quarterly report, and any regulator/DOJ/FTC action in 60–180 days.

Trade implications: Directional: consider a measured long in AXP (2–3% portfolio weight) over 6–12 months to capture EPS guide re-rating, funded by trimming cyclically exposed banks (BAC/JPM) by 1–2%. Pair trade: long AXP vs short BAC (1:1 notional) to capture premium spread if affluent spend holds while broader consumer credit softens. Options: buy a 6–9 month AXP 10–15% OTM call spread to limit premium cost and sell a nearer-term 10% OTM put spread to monetize elevated IV; alternatively buy a 3-month 8–10% OTM put for downside protection around macro releases. Sector rotation: overweight Payments/Consumer Discretionary, underweight Regional Banks for the next 3–12 months.

Contrarian angles: The market is focused on expense-driven EPS miss but underestimates the return on strategic perks and GenAI-driven engagement — if retention lifts NPS and billed business grows >6% annually, AXP could re-rate higher over 12–24 months. The ~3% knee‑jerk move looks modestly overdone relative to execution risk; a >5% weakness intraday is a tactical buy window, while a >10% rally from here warrants trimming to realize gains. Historical parallel: past Amex premium-investment cycles (pre‑COVID) compressed near-term margins but drove multi-year spend and fee power. Unintended consequences: sustained elevated perks could normalize consumer expectations and force fee hikes or churn among price-sensitive cards, pressuring mid‑tier cohorts.

Key Decisions for Investors

• Establish a 2–3% long position in AXP with a 6–12 month horizon to capture guided EPS acceleration ($17.30–$17.90) assuming billed business growth ≥7%; add on any intraday weakness >5% from current levels and trim if position gains >10%.
• Initiate a relative-value pair: long AXP / short BAC (equal notional) for a 6–12 month trade to exploit resilience in affluent spend versus broader consumer credit exposure; target spread capture of 8–15% and stop-loss at 12% adverse move in either leg.
• Use options to shape risk: buy a 6–9 month AXP call spread 10–15% OTM (limit premium to <3% notional) and sell a 3-month 10% OTM put spread to finance premium while capping downside; alternatively buy a 3-month 8–10% OTM put if macro downside risk rises.
• Reduce exposure by 1–3% to regional and consumer cyclical banks (e.g., BAC, regions) over the next 30–90 days and rotate into Payment/Consumer Discretionary names (V, MA, select travel/restaurant partners) as leading indicators of affluent spend confirm outperformance.